Skip to content
10-Q

Quarterly Report

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.

0001144204-13-043270

← back to feed
Filed
Aug 6, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 5, 2013 67.16M sh
Capex Q2 2013 · Jun 30, 2013 $0
Capex Q2 2013 · Jun 30, 2013 $739.73K
Capex Q2 2013 · Jun 30, 2012 $23.12K
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$6.49M
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$206.46M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$26.95M
Cash And Equivalents Q2 2013 · Jun 30, 2013 $22.01M
Cash And Equivalents Q2 2013 · Dec 31, 2012 $28.42M
Cash And Equivalents Q2 2013 · Jun 30, 2012 $40.82M
Cash And Equivalents Q2 2013 · Dec 31, 2011 $41.11M
Cash And Equivalents Q2 2013 · Apr 2, 2002 $0
Stockholders Equity Q2 2013 · Jun 30, 2013 $19.77M
Stockholders Equity Q2 2013 · Dec 31, 2012 $25.92M
Total Liabilities Q2 2013 · Jun 30, 2013 $2.8M
Total Liabilities Q2 2013 · Dec 31, 2012 $3.01M
Current Assets Q2 2013 · Jun 30, 2013 $22.48M
Current Assets Q2 2013 · Dec 31, 2012 $28.78M
Total Assets Q2 2013 · Jun 30, 2013 $22.57M
Total Assets Q2 2013 · Dec 31, 2012 $28.93M
Sga Expense Q2 2013 · Jun 30, 2013 $1.19M
Sga Expense Q2 2013 · Jun 30, 2013 $2.8M
Sga Expense Q2 2013 · Jun 30, 2013 $33.7M
Sga Expense Q2 2013 · Jun 30, 2012 $1.44M
Sga Expense Q2 2013 · Jun 30, 2012 $3.36M
Rd Expense Q2 2013 · Jun 30, 2013 $1.9M
Rd Expense Q2 2013 · Jun 30, 2013 $3.86M
Rd Expense Q2 2013 · Jun 30, 2013 $166.37M
Rd Expense Q2 2013 · Jun 30, 2012 $4.7M
Rd Expense Q2 2013 · Jun 30, 2012 $13.39M
Net Income Q2 2013 · Jun 30, 2013 −$3.34M
Net Income Q2 2013 · Jun 30, 2013 −$7.25M
Net Income Q2 2013 · Jun 30, 2013 −$222.31M
Net Income Q2 2013 · Jun 30, 2012 −$7.87M
Net Income Q2 2013 · Jun 30, 2012 −$23.43M
Operating Income Q2 2013 · Jun 30, 2013 −$3.34M
Operating Income Q2 2013 · Jun 30, 2013 −$7.26M
Operating Income Q2 2013 · Jun 30, 2013 −$227.08M
Operating Income Q2 2013 · Jun 30, 2012 −$7.89M
Operating Income Q2 2013 · Jun 30, 2012 −$23.48M